Abel E L
Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI 48201.
Physiol Behav. 1994 Aug;56(2):355-8. doi: 10.1016/0031-9384(94)90206-2.
The mechanism of adverse imipramine-induced reactions (jitteriness, convulsions) was investigated by precipitating such reactions in rats with three injections (IP) of imipramine (5-40 mg/kg) at 24, 5, and 1 h before testing, and comparing their occurrence with comparable treatments using specific noradrenergic and serotonergic reuptake inhibitors [nortriptyline (10 or 30 mg/kg, IP), citalopram (0.5-5.0 mg/kg, IP)]. This initial study indicated that these reactions were mediated by imipramine's noradrenergic effects. Subsequent combinations of imipramine and an alpha 2 agonist (clonidine, 5 mg/kg) and antagonist (yohimbine, 2 mg/kg), and a beta-adrenergic antagonist (propranolol, 2 or 5 mg/kg) (all administered IP 0.5 h after the last injection of imipramine) suggested imipramine's adverse effects were mediated by alpha 2 receptors. The possible involvement of the locus ceruleus in these effects was considered.
通过在测试前24、5和1小时给大鼠腹腔注射三次丙咪嗪(5 - 40毫克/千克)引发此类反应,并将其发生率与使用特定去甲肾上腺素能和5-羟色胺能再摄取抑制剂[去甲替林(10或30毫克/千克,腹腔注射)、西酞普兰(0.5 - 5.0毫克/千克,腹腔注射)]的类似处理进行比较,研究了丙咪嗪引起的不良反应(神经过敏、惊厥)的机制。这项初步研究表明,这些反应是由丙咪嗪的去甲肾上腺素能作用介导的。随后将丙咪嗪与α2激动剂(可乐定,5毫克/千克)、拮抗剂(育亨宾,2毫克/千克)以及β肾上腺素能拮抗剂(普萘洛尔,2或5毫克/千克)联合使用(所有药物均在最后一次注射丙咪嗪后0.5小时腹腔注射),结果表明丙咪嗪的不良反应是由α2受体介导的。同时考虑了蓝斑在这些作用中可能的参与情况。